(Q41710447)

English

Cystoid macular edema and anterior uveitis associated with latanoprost use. Experience and incidence in a retrospective review of 94 patients

scientific article published on February 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

7 October 2017

Cystoid macular edema and anterior uveitis associated with latanoprost use. Experience and incidence in a retrospective review of 94 patients (English)

1 reference

Europe PubMed Central

7 October 2017

cystoid macular edema

1 reference

based on heuristic

inferred from title

anterior uveitis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

R E Warwar

1

1 reference

Europe PubMed Central

7 October 2017

J D Bullock

2

1 reference

Europe PubMed Central

7 October 2017

D Ballal

3

1 reference

Europe PubMed Central

7 October 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 February 1998

1 reference

Europe PubMed Central

7 October 2017

1 reference

Europe PubMed Central

7 October 2017

105

1 reference

Europe PubMed Central

7 October 2017

2

1 reference

Europe PubMed Central

7 October 2017

263-268

1 reference

Europe PubMed Central

7 October 2017

The effects on aqueous dynamics of PhXA41, a new prostaglandin F2 alpha analogue, after topical application in normal and ocular hypertensive human eyes

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2898%2992977-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning. A comparison with timolol. Scandinavian Latanoprost Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2898%2992977-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A six-month, randomized, double-masked study comparing latanoprost with timolol in open-angle glaucoma and ocular hypertension. The Latanoprost Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2898%2992977-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of latanoprost and timolol in primary open-angle glaucoma and ocular hypertension. A 12-week study

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2898%2992977-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduction of intraocular pressure with treatment of latanoprost once daily in patients with normal-pressure glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2898%2992977-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma: a six-month masked, multicenter trial in the United States. The United States Latanoprost Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2898%2992977-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Latanoprost, a prostaglandin analog, for glaucoma therapy. Efficacy and safety after 1 year of treatment in 198 patients. Latanoprost Study Groups.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2898%2992977-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostaglandin and eye.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2898%2992977-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostaglandin and non-prostaglandin mediated breakdown of the blood-aqueous barrier

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2898%2992977-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The effects of prostaglandin F2 alpha in the human eye

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2898%2992977-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostaglandin F2 alpha-isopropylester eye drops: effects in normal human eyes

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2898%2992977-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of topical flurbiprofen and indomethacin in preventing pseudophakic cystoid macular edema. Flurbiprofen-CME Study Group I

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2898%2992977-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Improvement in visual acuity in chronic aphakic and pseudophakic cystoid macular edema after treatment with topical 0.5% ketorolac tromethamine

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2898%2992977-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Adverse side effects associated with latanoprost.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2898%2992977-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0161-6420(98)92977-3

1 reference

Europe PubMed Central

7 October 2017

1 reference

Europe PubMed Central

7 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41710447&oldid=2104262389"